Pzena Investment Management LLC lessened its position in TriMas Co. (NASDAQ:TRS – Free Report) by 1.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,120,612 shares of the industrial products company’s stock after selling 21,935 shares during the period. Pzena Investment Management LLC owned about 0.05% of TriMas worth $52,146,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Wellington Management Group LLP lifted its stake in shares of TriMas by 10.7% in the third quarter. Wellington Management Group LLP now owns 2,619,359 shares of the industrial products company’s stock worth $66,872,000 after buying an additional 252,537 shares in the last quarter. Bellecapital International Ltd. bought a new position in shares of TriMas in the fourth quarter worth approximately $29,160,000. State Street Corp lifted its position in TriMas by 4.1% during the third quarter. State Street Corp now owns 994,114 shares of the industrial products company’s stock valued at $25,380,000 after purchasing an additional 39,497 shares during the period. Barington Capital Group L.P. lifted its position in TriMas by 4.3% during the third quarter. Barington Capital Group L.P. now owns 608,000 shares of the industrial products company’s stock valued at $15,522,000 after purchasing an additional 25,000 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in TriMas by 3.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 605,502 shares of the industrial products company’s stock valued at $14,889,000 after purchasing an additional 22,656 shares during the period. Institutional investors own 99.42% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on the stock. StockNews.com upgraded shares of TriMas from a “sell” rating to a “hold” rating in a research report on Wednesday, November 13th. BWS Financial restated a “buy” rating and set a $40.00 price objective on shares of TriMas in a research report on Friday, February 28th.
Insider Transactions at TriMas
In other TriMas news, Director Jeffrey A. Fielkow purchased 2,500 shares of the company’s stock in a transaction dated Friday, February 28th. The shares were acquired at an average price of $20.78 per share, for a total transaction of $51,950.00. Following the purchase, the director now directly owns 11,013 shares of the company’s stock, valued at $228,850.14. The trade was a 29.37 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Scott A. Mell sold 2,218 shares of TriMas stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $22.54, for a total transaction of $49,993.72. Following the transaction, the chief financial officer now owns 26,288 shares in the company, valued at $592,531.52. This represents a 7.78 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.
TriMas Stock Down 0.4 %
Shares of TriMas stock opened at $24.15 on Tuesday. The company has a market cap of $980.08 million, a price-to-earnings ratio of 37.73 and a beta of 0.65. The company’s 50 day moving average is $23.58 and its 200 day moving average is $25.07. TriMas Co. has a twelve month low of $19.33 and a twelve month high of $28.51. The company has a quick ratio of 1.44, a current ratio of 2.83 and a debt-to-equity ratio of 0.60.
TriMas Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 28th were paid a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a dividend yield of 0.66%. The ex-dividend date of this dividend was Friday, February 28th. TriMas’s dividend payout ratio is presently 27.12%.
TriMas Company Profile
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Read More
- Five stocks we like better than TriMas
- 3 Fintech Stocks With Good 2021 Prospects
- How to Protect Your Portfolio When Inflation Is Rising
- How to Use the MarketBeat Dividend Calculator
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- How to Invest in Biotech Stocks
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Co. (NASDAQ:TRS – Free Report).
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.